Observational studyJournal of neurology, neurosurgery, and psychiatry2026

Tysabri Observational Program (TOP): long-term safety and effectiveness of natalizumab treatment in relapsing-remitting multiple sclerosis over 15 years.

Helmut Butzkueven et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.